MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells-Reference-Cited by-同舟云学术

MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells

Published:2017-11-21 Issue:4 Volume:32 Page:1003-1015
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Botta C^ORCID,Cucè M,Pitari M R,Caracciolo D,Gullà A,Morelli E,Riillo C,Biamonte L,Gallo Cantafio M E,Prabhala R,Mignogna C^ORCID,Di Vito A,Altomare E,Amodio N,Di Martino M T,Correale P,Rossi M,Giordano A,Munshi N C,Tagliaferri P,Tassone P

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2017336.pdf

Reference61 articles.

1. Botta C, Ciliberto D, Rossi M, Staropoli N, Cucè M, Galeano T et al. Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients. Blood Adv 2017; 1: 455–466.

2. Rossi M, Botta C, Correale P, Tassone P, Tagliaferri P . Immunologic microenvironment and personalized treatment in multiple myeloma. Expert Opin Biol Ther 2013; 13 (Suppl 1): S83–93.

3. Prabhala RH, Fulciniti M, Pelluru D, Rashid N, Nigroiu A, Nanjappa P et al. Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma. Leukemia 2016; 30: 379–389.

4. Murray ME, Gavile CM, Nair JR, Koorella C, Carlson LM, Buac D et al. CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma. Blood 2014; 123: 3770–3779.

5. Gorgun GT, Whitehill G, Anderson JL, Hideshima T, Maguire C, Laubach J et al. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans. Blood 2013; 121: 2975–2987.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-21, miR-221, miR-29 and miR-34 are distinguishable molecular features of a metabolically unhealthy phenotype in young adults;PLOS ONE;2024-04-25

2. Engineered Extracellular Vesicles Driven by Erythrocytes Ameliorate Bacterial Sepsis by Iron Recycling, Toxin Clearing and Inflammation Regulation;Advanced Science;2024-01-21

3. The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity;Frontiers in Immunology;2024-01-09

4. Dendritic Cells in the Tumor Microenvironment;Reference Module in Life Sciences;2024

5. Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma;Non-Coding RNA;2023-11-03